Drug major Pfizer Ltd today said it has completed the sale of its subsidiary PAPPL to Pfizer Animal Health India Ltd (PAHIL), which is owned by US-based Pfizer Inc, for Rs 471.60 crore.
Also read: Canada's Supreme Court strips Viagra patent from Pfizer
"..transaction of the sale of the entire equity stake by the company and its nominees in PAPPL (Pfizer Animal Pharma Pvt Ltd) to PAHIL has been completed and the company has received the consideration amount of Rs 471.60 crore," Pfizer said in a filing to BSE.
Pfizer Ltd had said earlier that the development is part of a global internal re-organisation taken up by its parent, Pfizer Inc, in July 2011 under which it was reviewing strategic alternatives for its global animal health business.
Pfizer's animal health business has presence primarily in the large animal health and poultry market segments and also includes rendering of marketing services. Pfizer scrip closed at Rs 1,135.35 on the BSE, down 1.43 per cent from its previous close.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
